课题基金 / 基金详情

Pathophysiological Mechanisms of Angiogenesis-Related Diseases

Pathophysiological Mechanisms of Angiogenesis-Related Diseases
血管生成相关疾病的病理生理机制
批准号:
18390115
负责人:
YONEMITSU Yoshikazu
金额:
$10.77万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2006
资助国家:
日本
项目状态:
已结题
起止时间:
2006 至 2007

项目摘要

项目成果

YONEMITSU Yoshikazu的其他基金

相关文献

中文摘要
翻译
本课题在2年的研究过程中,采用从细胞、动物模型到人体材料的综合研究方法,对血管生成相关疾病的遗传、分子和病理生理机制进行了研究,主要研究结果如下:1.我们阐明了单核细胞/巨噬细胞趋化蛋白-1(MCP 1)在FGF-2介导的血管再生过程中的关键作用(发表于Arteriosclr Thromb Vasc Biol 2006)。2.我们发现了一个新的蛋白激酶-C(PKC)eta的单核苷酸多态性(SNP),与脑梗死密切相关(发表在Nature Genetics 2006)。3.我们发现在人类动脉粥样硬化的非常早期过程中,在巨噬细胞积聚之前,氧化脂质在内膜下层沉积(发表于Arteriosclr Thromb Vasc Biol 2006)。4.我们建立了内源性生长因子抑制剂的双敲除小鼠系,即Spred-1和Spred-2。该品系的小鼠在第13.5天表现出胚胎致死性,这是由VEGFR 3信号传导引起的淋巴管异常发育引起的(Mol Cell Biol 2007)。5. VEGRR 1的一种配体胎盘生长因子(PlGF)在FGF-2介导的血管生成过程中支持VEGF-A的功能(Atherovirus 2008)。6. FGF-2上调VEGF-C表达,形成与PDGF-BB表达相关的功能性毛细血管和淋巴管网络(投稿中)。7.他汀类药物通过一氧化氮(NO)/内皮型一氧化氮合酶(eNOS)而非PDGF-BB介导的毛细血管成熟来恢复糖尿病状态下的血管内皮功能,为动脉粥样硬化性疾病和代谢综合征的治疗提供了新的思路。
英文摘要
During 2-years' research project, we performed integrated research approach, from cell, animal model, to human materials, to investigate the genetic, molecular, and pathophysiological mechanisms of angiogenesis-related diseases.Major findings obtained in this project were as follows; 1. We clarified the critical role of monocyte/macrophage chamoattractant protein-1 (MCP 1) during revascularization mediated by FGF-2 (published in Arteriosclr Thromb Vasc Biol 2006). 2. We identified a new single nucleotide polymorphism (SNP) of protein kinase-C (PKC) eta critically related to cerebral infarction (published in Nature Genetics 2006). 3. We discovered the deposition of oxidized lipids at subintimal layer prior to macrophage accumulation in very early process of human atherosclerosis (published in Arteriosclr Thromb Vasc Biol 2006). 4. We established a double knockout mouse line for endogenous growth factor inhibitors, namely Spred-1 and Spred-2. Mice of this line exhibited embryonic lethal at day 13.5, that were caused by abnormal development of lymphatic vessels due to VEGFR3 signaling (Mol Cell Biol 2007). 5. A ligand of VEGRR1, placental growth factor (PlGF), support the function of VEGF-A during FGF-2-mediated angiogenesis (Atherosclerosis 2008). 6. FGF-2 upregulates VEGF-C expression to form functional capillary and lymphatic network associated with PDGF-BB expression (manuscript under submission). 7. Statins restore vascular endothelial function under diabetic state nitric oxide (NO)/ endothelial NO syntase (eNOS), but not capillary maturation by PDGF-BB, is critical in this process.These findings should contribute the understanding of and new therapeutic approach to atherosclerotic diseases and metabolic syndrome.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
『Vascular regenaration〜Dawn of Vascular generative medici ne: Practial use in comingup』 (Ryuichi, Morishita edit) The third chapter Angiogenic Growth Factor i) Fibrobrlast Growth Factor (FGF)
《血管再生〜血管生成医学的黎明:未来的实际应用》(森下龙一编辑)第三章血管生成因子i)成纤维细胞生长因子(FGF)
DOI: --
发表时间: 2008
期刊: Shinko Trading CO LTD Publication Department 251
影响因子: --
作者: [Misu Y, Goshima Y, Yonemitsu Y]
通讯作者: Yonemitsu Y
特集 : 下肢慢性閉塞性動脈硬化症に対する血管新生療法の新展開 1.遺伝子療法 : 2)bFGF・FGF-2。
专题:下肢慢性动脉硬化闭塞症血管生成治疗新进展 1.基因治疗:2)bFGF/FGF-2。
DOI: --
发表时间: 2006
期刊: Angiology Frontier 5
影响因子: --
作者: [藤井孝明, 他]
通讯作者:
Gene Therapy Strategies using Recombinant Sendai Virus
使用重组仙台病毒的基因治疗策略
DOI: --
发表时间: 2008
期刊:
影响因子: --
作者: [鬼丸満穂, 他, 米満吉和, 米満吉和, Yonemitsu Y]
通讯作者: Yonemitsu Y
‘New Anticancer Technologies based on Recombinant Sendai Virus'
“基于重组仙台病毒的抗癌新技术”
DOI: --
发表时间: 2008
期刊:
影响因子: --
作者: [鬼丸満穂, 他, 米満吉和, 米満吉和, Yonemitsu Y, 米満 吉和, 米満吉和, Yonemitsu Y, 米満 吉和]
通讯作者: 米満 吉和
101
    Development of"immunostimulatory virotherapy"to treat various malignancies
    • 批准号:
      21390364
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.32万
    • 财政年份:
      2009
    • 负责人:
      YONEMITSU Yoshikazu
    • 依托单位:
    Basic Research for Complex Molecular Mechanisms of the Process of the Functional Angiogenesis : toward the development of technologies controlling the molecular target of pathological angiogenesis.
    • 批准号:
      16390118
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.54万
    • 财政年份:
      2004
    • 负责人:
      YONEMITSU Yoshikazu
    • 依托单位:
    Hierarchical Regulation of Multiple Angiogenic Growth Factors During 'Functional' Angiogenesis In Vivo
    • 批准号:
      14370072
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.54万
    • 财政年份:
      2002
    • 负责人:
      YONEMITSU Yoshikazu
    • 依托单位:
    Role of human cytomegalovirus infection and the expression of immediate early gene products (CMV-IE) in the pathogenesis of vascular lesion formations
    • 批准号:
      12470057
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.22万
    • 财政年份:
      2000
    • 负责人:
      YONEMITSU Yoshikazu
    • 依托单位: